Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 6733

Sort by

Sort Order Select

Journal Articles

Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein

Blood (2021) 138 (14): 1269–1277.

https://doi.org/10.1182/blood.2021012938

Published: 2021

Includes: Supplemental data

Journal Articles

Microscope diagnosis of MYH9-related thrombocytopenia

Alina Sadaf, Russell E. Ware

Blood (2021) 138 (11): 1000.

https://doi.org/10.1182/blood.2021012044

Published: 2021

Journal Articles

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia

Blood (2021) 138 (11): 992–996.

https://doi.org/10.1182/blood.2021012479

Published: 2021

Includes: Supplemental data

Journal Articles

Understanding VITT(ual) reality

Lubica Rauova, Mortimer Poncz

Blood (2021) 138 (4): 285–286.

https://doi.org/10.1182/blood.2021012524

Published: 2021

Journal Articles

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

Andreas Tiede, Ulrich J. Sachs, Andreas Czwalinna, Sonja Werwitzke, Rolf Bikker, Joachim K. Krauss, Frank Donnerstag, Karin Weißenborn, Günter Höglinger, Benjamin Maasoumy, Heiner Wedemeyer, Arnold Ganser

Blood (2021) 138 (4): 350–353.

https://doi.org/10.1182/blood.2021011958

Published: 2021

Includes: Supplemental data

Journal Articles

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know

Gowthami M. Arepally, Thomas L. Ortel

Blood (2021) 138 (4): 293–298.

https://doi.org/10.1182/blood.2021012152

Published: 2021

Journal Articles

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination

Stefan Handtke, Martina Wolff, Carlo Zaninetti, Jan Wesche, Linda Schönborn, Konstanze Aurich, Lena Ulm, Nils-Olaf Hübner, Karsten Becker, Thomas Thiele, Andreas Greinacher

Blood (2021) 137 (26): 3656–3659.

https://doi.org/10.1182/blood.2021012064

Published: 2021

Includes: Supplemental data

Journal Articles

RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells

Brian Estevez, Sara Borst, Danuta Jarocha, Varun Sudunagunta, Michael Gonzalez, James Garifallou, Hakon Hakonarson, Peng Gao, Kai Tan, Paul Liu, Sumedha Bagga, Nicholas Holdreith, Wei Tong, Nancy Speck, Deborah L. French, Paul Gadue, Mortimer Poncz

Blood (2021) 137 (19): 2662–2675.

https://doi.org/10.1182/blood.2020006389

Published: 2021

Includes: Supplemental data

Journal Articles

How I treat microangiopathic hemolytic anemia in patients with cancer

M. R. Thomas, M. Scully

Blood (2021) 137 (10): 1310–1317.

https://doi.org/10.1182/blood.2019003810

Published: 2021

Journal Articles

Pal K, Nowak R, Billington N, et al. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9 -related disease. Blood. 2020;135(21):1887-1898.

Blood (2020) 136 (6): 771.

https://doi.org/10.1182/blood.2020007850

Published: 2020

Journal Articles

The role of AGK in thrombocytopoiesis and possible therapeutic strategies

Haojie Jiang, Zhuo Yu, Nan Ding, Mina Yang, Lin Zhang, Xuemei Fan, Yuan Zhou, Qiang Zou, Jian Hou, Junke Zheng, Lei Zhang, Yanyan Xu, Junling Liu

Blood (2020) 136 (1): 119–129.

https://doi.org/10.1182/blood.2019003851

Published: 2020

Includes: Supplemental data

Journal Articles

Mechanisms of anti-GPIbα antibody–induced thrombocytopenia in mice

Yosuke Morodomi, Sachiko Kanaji, Eric Won, Zaverio M. Ruggeri, Taisuke Kanaji

Blood (2020) 135 (25): 2292–2301.

https://doi.org/10.1182/blood.2019003770

Published: 2020

Includes: Supplemental data

Journal Articles

Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug–induced thrombocytopenia

Taro Tochigi, Toshihiro Miyamoto, Kiwamu Hatakeyama, Teppei Sakoda, Daisuke Ishihara, Hidetoshi Irifune, Takahiro Shima, Koji Kato, Takahiro Maeda, Takumi Ito, Hiroshi Handa, Koichi Akashi, Yoshikane Kikushige

Blood (2020) 135 (24): 2146–2158.

https://doi.org/10.1182/blood.2019003749

Published: 2020

Includes: Supplemental data

Journal Articles

Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report

Lauri M. Burroughs, Aleksandra Petrovic, Ruta Brazauskas, Xuerong Liu, Linda M. Griffith, Hans D. Ochs, Jack J. Bleesing, Stephanie Edwards, Christopher C. Dvorak, Sonali Chaudhury, Susan E. Prockop, Ralph Quinones, Frederick D. Goldman, Troy C. Quigg, Shanmuganathan Chandrakasan, Angela R. Smith, Suhag Parikh, Blachy J. Dávila Saldaña, Monica S. Thakar, Rachel Phelan, Shalini Shenoy, Lisa R. Forbes, Caridad Martinez, Deepak Chellapandian, Evan Shereck, Holly K. Miller, Neena Kapoor, Jessie L. Barnum, Hey Chong, David C. Shyr, Karin Chen, Rolla Abu-Arja, Ami J. Shah, Katja G. Weinacht, Theodore B. Moore, Avni Joshi, Kenneth B. DeSantes, Alfred P. Gillio, Geoffrey D. E. Cuvelier, Michael D. Keller, Jacob Rozmus, Troy Torgerson, Michael A. Pulsipher, Elie Haddad, Kathleen E. Sullivan, Brent R. Logan, Donald B. Kohn, Jennifer M. Puck, Luigi D. Notarangelo, Sung-Yun Pai, David J. Rawlings, Morton J. Cowan

Blood (2020) 135 (23): 2094–2105.

https://doi.org/10.1182/blood.2019002939

Published: 2020

Journal Articles

Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9 -related disease

Kasturi Pal, Roberta Nowak, Neil Billington, Rong Liu, Arit Ghosh, James R. Sellers, Velia M. Fowler

Blood (2020) 135 (21): 1887–1898.

https://doi.org/10.1182/blood.2019003064

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Overview of Castleman disease

Angela Dispenzieri, David C. Fajgenbaum

Blood (2020) 135 (16): 1353–1364.

https://doi.org/10.1182/blood.2019000931

Published: 2020

Journal Articles

Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial

Régis Peffault de Latour, Sylvie Chevret, Anna Lisa Ruggeri, Felipe Suarez, Laetitia Souchet, David Michonneau, Flore Sicre de Fontbrune, Tereza Coman, Nathalie Dhedin, Marie Thérèse Rubio, Stéphanie Nguyen, Mohamad Mohty, Gérard Socié

Blood (2020) 135 (3): 227–229.

https://doi.org/10.1182/blood.2019000358

Published: 2020

Includes: Supplemental data

Journal Articles

Germline mutations in the transcription factor IKZF5 cause thrombocytopenia

Blood (2019) 134 (23): 2070–2081.

https://doi.org/10.1182/blood.2019000782

Published: 2019

Includes: Supplemental data

Journal Articles

Pegasus causes inherited thrombocytopenia

Alessandro M. Vannucchi

Blood (2019) 134 (23): 2000–2002.

https://doi.org/10.1182/blood.2019002181

Published: 2019

Journal Articles

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Blood (2019) 134 (Supplement_2): LBA-3.

https://doi.org/10.1182/blood-2019-132405

Published: 2019

NARROW

Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein

Microscope diagnosis of MYH9-related thrombocytopenia

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia

Understanding VITT(ual) reality

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination

RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells

How I treat microangiopathic hemolytic anemia in patients with cancer

Pal K, Nowak R, Billington N, et al. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9 -related disease. Blood. 2020;135(21):1887-1898.

The role of AGK in thrombocytopoiesis and possible therapeutic strategies

Mechanisms of anti-GPIbα antibody–induced thrombocytopenia in mice

Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug–induced thrombocytopenia

Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report

Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9 -related disease

Overview of Castleman disease

Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial

Germline mutations in the transcription factor IKZF5 cause thrombocytopenia

Pegasus causes inherited thrombocytopenia

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only